Skip to content

Validation of CT Angiography and Magnetic Resonance Imaging protocols for characterization and quantification of atherosclerosis in carotid arteries.

Validation of CT Angiography and Magnetic Resonance Imaging protocols for characterization and quantification of atherosclerosis in carotid arteries. - Carotid imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39409
Enrollment
150
Registered
2008-08-06
Start date
2008-09-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with cerebrovascular symptoms (TIA, minor stroke) in the last six months. - CTA of the carotid arteries at the Erasmus Medical Center during the last 2 months (CTA is performed for clinical work-up). - Scheduled endarterectomy of a carotid artery - Signed informed consent - At least 50 years old - Patients who have a documented allergy to MRI contrast media are eligible for MRI, but will not undergo a contrast-enhanced scan. - Patients with a renal clearance (eGFR)

Exclusion criteria

Exclusion criteria: - Woman who are pregnant or lactating. - Patients who are hemodynamically unstable. - Having any physical or mental status that interferes with the informed consent procedure. - Not being able to remain lying down for at least 40-45 min (e.g. patients with unstable angina, dyspnea at rest, severe pain at rest, severe back pain) - Contraindications for MRI (e.g. claustrophobia, pacemaker,*)

Design outcomes

Primary

MeasureTime frame
- MRI Plaque quantification by basic morphological parameters (Plaque burden, Lumen, Outer wall area) and plaque composition (Fibrous cap, ulcerations, lipid rich necrotic core (LC/NR), calcifications, intraplaque hemorrhage) - Histology from the removed atherosclerotic plaque

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)